 Tyler Buckner
Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemophilia A | 33 | 2025 | 147 | 10.260 |
Why?
| | Hemophilia B | 12 | 2025 | 66 | 4.250 |
Why?
| | Antibodies, Bispecific | 4 | 2025 | 64 | 2.450 |
Why?
| | Pain | 8 | 2025 | 777 | 2.260 |
Why?
| | Quality of Life | 17 | 2024 | 3166 | 1.700 |
Why?
| | Hemorrhage | 8 | 2025 | 809 | 1.400 |
Why?
| | Antibodies, Monoclonal, Humanized | 4 | 2025 | 985 | 1.290 |
Why?
| | Hemarthrosis | 3 | 2023 | 22 | 1.140 |
Why?
| | Pain Management | 4 | 2025 | 405 | 0.940 |
Why?
| | Factor VIIa | 2 | 2025 | 43 | 0.930 |
Why?
| | Anxiety | 7 | 2024 | 1104 | 0.820 |
Why?
| | Factor VIII | 6 | 2023 | 104 | 0.800 |
Why?
| | Depression | 7 | 2024 | 1533 | 0.780 |
Why?
| | Venous Thromboembolism | 3 | 2024 | 324 | 0.770 |
Why?
| | Pain Measurement | 3 | 2025 | 552 | 0.760 |
Why?
| | Venous Thrombosis | 3 | 2016 | 194 | 0.750 |
Why?
| | Patient Reported Outcome Measures | 9 | 2024 | 487 | 0.740 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2022 | 182 | 0.690 |
Why?
| | Antifibrinolytic Agents | 1 | 2022 | 62 | 0.670 |
Why?
| | Physical Therapists | 1 | 2022 | 64 | 0.660 |
Why?
| | Surveys and Questionnaires | 14 | 2024 | 6021 | 0.580 |
Why?
| | Adult | 28 | 2025 | 40262 | 0.500 |
Why?
| | Young Adult | 15 | 2025 | 13990 | 0.490 |
Why?
| | Antibodies | 2 | 2015 | 401 | 0.470 |
Why?
| | Humans | 49 | 2026 | 144261 | 0.460 |
Why?
| | Factor V Deficiency | 1 | 2014 | 2 | 0.440 |
Why?
| | Hydroxyurea | 1 | 2014 | 34 | 0.430 |
Why?
| | Postoperative Hemorrhage | 3 | 2022 | 104 | 0.420 |
Why?
| | United States | 13 | 2025 | 15876 | 0.420 |
Why?
| | Severity of Illness Index | 4 | 2024 | 2917 | 0.410 |
Why?
| | Anticoagulants | 3 | 2024 | 721 | 0.410 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 576 | 0.400 |
Why?
| | Middle Aged | 19 | 2025 | 35762 | 0.390 |
Why?
| | Male | 28 | 2025 | 72035 | 0.380 |
Why?
| | Maxillary Sinus | 1 | 2012 | 11 | 0.380 |
Why?
| | Symptom Assessment | 1 | 2014 | 137 | 0.380 |
Why?
| | Caregivers | 2 | 2018 | 1047 | 0.380 |
Why?
| | Adolescent | 12 | 2025 | 22281 | 0.370 |
Why?
| | Thrombophlebitis | 1 | 2012 | 12 | 0.360 |
Why?
| | Disability Evaluation | 1 | 2014 | 308 | 0.360 |
Why?
| | Patient Education as Topic | 1 | 2017 | 777 | 0.350 |
Why?
| | Pulmonary Embolism | 2 | 2012 | 243 | 0.340 |
Why?
| | Warfarin | 1 | 2012 | 170 | 0.330 |
Why?
| | Anemia, Sickle Cell | 1 | 2014 | 309 | 0.320 |
Why?
| | Survivors | 1 | 2014 | 516 | 0.320 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 192 | 0.310 |
Why?
| | Delivery of Health Care | 1 | 2017 | 940 | 0.310 |
Why?
| | Aged | 10 | 2025 | 25850 | 0.280 |
Why?
| | Postoperative Complications | 2 | 2022 | 2916 | 0.270 |
Why?
| | Lung Diseases | 1 | 2014 | 787 | 0.270 |
Why?
| | Female | 20 | 2025 | 77976 | 0.270 |
Why?
| | Joint Diseases | 2 | 2018 | 62 | 0.260 |
Why?
| | Genetic Therapy | 3 | 2024 | 313 | 0.250 |
Why?
| | Blood Coagulation Disorders, Inherited | 1 | 2026 | 4 | 0.250 |
Why?
| | Child, Preschool | 6 | 2025 | 11774 | 0.240 |
Why?
| | Autopsy | 1 | 2006 | 94 | 0.240 |
Why?
| | Population Surveillance | 2 | 2020 | 483 | 0.230 |
Why?
| | Cross-Sectional Studies | 8 | 2024 | 5813 | 0.230 |
Why?
| | Recombinant Proteins | 3 | 2025 | 1367 | 0.230 |
Why?
| | Prospective Studies | 3 | 2025 | 7970 | 0.220 |
Why?
| | Neoplasms | 2 | 2024 | 2870 | 0.210 |
Why?
| | Cause of Death | 1 | 2006 | 464 | 0.210 |
Why?
| | Health Equity | 1 | 2026 | 129 | 0.200 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.200 |
Why?
| | Research | 2 | 2026 | 428 | 0.200 |
Why?
| | Health Services | 1 | 2023 | 114 | 0.180 |
Why?
| | Child | 6 | 2025 | 22537 | 0.180 |
Why?
| | Treatment Outcome | 3 | 2025 | 11643 | 0.170 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 264 | 0.170 |
Why?
| | Hemostatics | 1 | 2021 | 61 | 0.170 |
Why?
| | Premedication | 1 | 2020 | 42 | 0.160 |
Why?
| | Medicare | 1 | 2025 | 881 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1559 | 0.150 |
Why?
| | Biomedical Research | 1 | 2026 | 709 | 0.150 |
Why?
| | Practice Patterns, Physicians' | 2 | 2022 | 1347 | 0.150 |
Why?
| | Blood Coagulation Disorders | 1 | 2021 | 189 | 0.140 |
Why?
| | Cost of Illness | 1 | 2021 | 319 | 0.140 |
Why?
| | Physical Therapy Modalities | 1 | 2022 | 332 | 0.140 |
Why?
| | Activities of Daily Living | 2 | 2018 | 440 | 0.130 |
Why?
| | Pregnancy Complications | 1 | 2023 | 592 | 0.130 |
Why?
| | Health Care Costs | 1 | 2021 | 421 | 0.130 |
Why?
| | Musculoskeletal Pain | 1 | 2017 | 43 | 0.130 |
Why?
| | Comorbidity | 2 | 2018 | 1646 | 0.120 |
Why?
| | Prevalence | 2 | 2020 | 2815 | 0.120 |
Why?
| | Blood Coagulation Factor Inhibitors | 1 | 2015 | 4 | 0.110 |
Why?
| | Publications | 1 | 2014 | 48 | 0.110 |
Why?
| | Patient Acceptance of Health Care | 1 | 2021 | 878 | 0.100 |
Why?
| | Risk Factors | 3 | 2020 | 10699 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1131 | 0.100 |
Why?
| | Infant, Newborn | 2 | 2020 | 6424 | 0.100 |
Why?
| | Infant | 3 | 2020 | 10022 | 0.100 |
Why?
| | Remission, Spontaneous | 1 | 2012 | 40 | 0.090 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2012 | 28 | 0.090 |
Why?
| | Self Report | 1 | 2017 | 863 | 0.090 |
Why?
| | Medical Oncology | 2 | 2024 | 331 | 0.090 |
Why?
| | Quality Improvement | 1 | 2021 | 1285 | 0.090 |
Why?
| | Sickle Cell Trait | 1 | 2012 | 15 | 0.090 |
Why?
| | Odds Ratio | 2 | 2015 | 1072 | 0.090 |
Why?
| | Case Management | 1 | 2012 | 66 | 0.090 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 93 | 0.090 |
Why?
| | Thrombophilia | 1 | 2012 | 88 | 0.090 |
Why?
| | Cohort Studies | 2 | 2025 | 5935 | 0.080 |
Why?
| | Sex Factors | 1 | 2017 | 2096 | 0.080 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2016 | 370 | 0.080 |
Why?
| | Hospitalization | 1 | 2021 | 2424 | 0.080 |
Why?
| | North Carolina | 1 | 2010 | 128 | 0.080 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 126 | 0.080 |
Why?
| | Risk | 1 | 2012 | 909 | 0.070 |
Why?
| | Ultrasonography | 1 | 2012 | 768 | 0.070 |
Why?
| | Incidental Findings | 1 | 2006 | 80 | 0.060 |
Why?
| | Insurance Claim Review | 1 | 2025 | 82 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2006 | 175 | 0.060 |
Why?
| | Logistic Models | 1 | 2010 | 2104 | 0.050 |
Why?
| | Factor IX | 1 | 2024 | 51 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2022 | 17009 | 0.050 |
Why?
| | Dependovirus | 1 | 2024 | 79 | 0.050 |
Why?
| | Cooperative Behavior | 1 | 2026 | 462 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2359 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3403 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8243 | 0.040 |
Why?
| | Half-Life | 1 | 2021 | 151 | 0.040 |
Why?
| | Risk Assessment | 1 | 2010 | 3637 | 0.040 |
Why?
| | Plasmapheresis | 1 | 2020 | 22 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2023 | 674 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 643 | 0.040 |
Why?
| | Choice Behavior | 1 | 2021 | 177 | 0.040 |
Why?
| | Rituximab | 1 | 2020 | 209 | 0.040 |
Why?
| | Patient Preference | 1 | 2021 | 221 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 803 | 0.040 |
Why?
| | Medication Adherence | 1 | 2023 | 512 | 0.040 |
Why?
| | Primary Prevention | 1 | 2020 | 219 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 3057 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2020 | 240 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1834 | 0.030 |
Why?
| | Swine | 1 | 2020 | 831 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2023 | 674 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 478 | 0.030 |
Why?
| | Psychometrics | 1 | 2020 | 730 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2021 | 540 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 833 | 0.030 |
Why?
| | Time Factors | 1 | 2006 | 7155 | 0.030 |
Why?
| | Perception | 1 | 2018 | 377 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2023 | 1147 | 0.030 |
Why?
| | Demography | 1 | 2015 | 284 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 519 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4278 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7180 | 0.020 |
Why?
| | Animals | 1 | 2020 | 38030 | 0.010 |
Why?
|
|
Buckner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|